- Tom HarkinSenator
Sen. Harkin: Stop Alzheimer's by 2020 & Support Vital Research Today
As loved ones age and show symptoms of Alzheimer's, families all across America are faced with the devastating effects of the disease. With 5.4 million current victims, one in three American families knows the costs of this disease first hand. Odds are, one of those families is yours.
Even more, Alzheimer's and other high-cost chronic conditions pose significant challenges to the public health – and fiscal health – of the nation.
Alzheimer's disease alone will cost the nation $183 billion this year, 70 percent of which will be borne by Medicare and Medicaid.
Unless therapies to significantly slow or modify Alzheimer's disease, reverse it, cure it or prevent it are developed soon, total annual direct costs of the disease will explode to exceed $1 trillion by 2050.
The federal government spends hundreds of billions of dollars each year caring for patients suffering from Alzheimer's disease and other chronic conditions. Our government, the private sector, and families affected by the disease can't afford to NOT focus on advanced research.
The SPRINT Agenda Act is an innovative vision to attack Alzheimer's and other high-cost chronic conditions by expediting the discovery of new therapies and accelerating their development and review. SPRINT spurs private innovation and most importantly, speeds the process for drugs to get approved, getting new treatments to suffering families faster.
Each family's story with Alzheimer's is different and we hope that you'll share yours. But one thing is the same: we all understand the importance of innovations in treatments.
Tell Congress today to support the SPRINT Agenda Act and help fight against chronic conditions like Alzheimer's, to protect the public and fiscal health of America.
As an advocate devoted to finding a cure for Alzheimer’s, I am writing to urge you to support the Spending Reductions through Innovations in Therapies (SPRINT) Agenda Act.
SPRINT is an innovative vision to attack Alzheimer's and other high-cost chronic conditions by expediting the discovery of new therapies and accelerating their development and review. With the United States government – for the first time ever – moving ahead to develop a National Alzheimer's Plan that establishes a national goal for the prevention or effective treatment of Alzheimer’s by 2025 or earlier, SPRINT will provide the tools necessary to achieve it.
At its core, SPRINT seeks to deliver therapies to patients suffering from Alzheimer's and other high-cost chronic conditions far more quickly and cost-effectively than today by shortening the therapeutic discovery and development pipeline.
SPRINT recognizes that the nation has two fundamental choices when it comes to paying for Alzheimer's and other high-cost diseases. One choice is to incur ever-increasing health care expenditures projected to exceed, in the case of Alzheimer's disease alone, $1 trillion by 2050. The second is to accelerate the discovery and development of therapies to prevent and effectively treat the disease and enable patients to live healthier and more productive lives. SPRINT believes a healthier nation is possible and pursues this vision by applying well-proven public-private partnership models to bridge the therapeutic "valley of death" and deliver safe and effective treatments to patients as quickly as possible.
Chronic diseases don't know politics; SPRINT already has bipartisan, bicameral cosponsors. Help alleviate the burden of Alzheimer’s and other high-cost chronic diseases on families across the country in the near future and help cure this devastating disease.
USAgainstAlzheimer's started this petition with a single signature, and now has 547 supporters. Start a petition today to change something you care about.